Literature DB >> 2523954

T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice.

C Boitard1, R Yasunami, M Dardenne, J F Bach.   

Abstract

The nonobese diabetic (NOD) mouse has recently been introduced as a model for insulin-dependent diabetes mellitus. The role of regulatory T cells in the development of antipancreatic autoimmunity in this model remains unclear. To evaluate the presence of suppressive phenomena, we used disease transfer by spleen cells from diabetic NOD mice into preirradiated adult recipients as a model for accelerated disease. Suppressor phenomena were detected by testing the protection afforded by lymphoid cells from nondiabetic NOD mice against diabetes transfer in irradiated recipients. Transfer of diabetes was delayed by reconstituting recipients with spleen cells from nondiabetic NOD donors. The greatest protection against diabetes transfer was conferred by spleen cells from 8-wk-old nondiabetic female NOD mice. Depletion experiments showed that the protection was dependent on CD4+ cells. Protection was also detected within thymic cells from nondiabetic NOD mice and protection conferred by spleen cells was abrogated by thymectomy of nondiabetic female, but not male, NOD donors at 3 wk of age. These findings indicate that suppressive CD4+ T cells that are dependent on the presence of the thymus may delay the onset of diabetes in female diabetes-prone NOD mice.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2523954      PMCID: PMC2189316          DOI: 10.1084/jem.169.5.1669

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique.

Authors:  H Acha-Orbea; H O McDevitt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

2.  The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex.

Authors:  M Hattori; J B Buse; R A Jackson; L Glimcher; M E Dorf; M Minami; S Makino; K Moriwaki; H Kuzuya; H Imura
Journal:  Science       Date:  1986-02-14       Impact factor: 47.728

3.  Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice.

Authors:  T Koike; Y Itoh; T Ishii; I Ito; K Takabayashi; N Maruyama; H Tomioka; S Yoshida
Journal:  Diabetes       Date:  1987-04       Impact factor: 9.461

4.  Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice.

Authors:  L S Wicker; B J Miller; Y Mullen
Journal:  Diabetes       Date:  1986-08       Impact factor: 9.461

5.  Prevention of type I diabetes in nonobese diabetic mice by allogenic bone marrow transplantation.

Authors:  S Ikehara; H Ohtsuki; R A Good; H Asamoto; T Nakamura; K Sekita; E Muso; Y Tochino; T Ida; H Kuzuya
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

6.  Promotion of spontaneous diabetes in non-obese diabetes-prone mice by cyclophosphamide.

Authors:  M Harada; S Makino
Journal:  Diabetologia       Date:  1984-12       Impact factor: 10.122

7.  Preventive effects of cyclosporin on diabetes in NOD mice.

Authors:  Y Mori; M Suko; H Okudaira; I Matsuba; A Tsuruoka; A Sasaki; H Yokoyama; T Tanase; T Shida; M Nishimura
Journal:  Diabetologia       Date:  1986-04       Impact factor: 10.122

8.  Predominance of T lymphocytes in pancreatic islets and spleen of pre-diabetic non-obese diabetic (NOD) mice: a longitudinal study.

Authors:  A Miyazaki; T Hanafusa; K Yamada; J Miyagawa; H Fujino-Kurihara; H Nakajima; K Nonaka; S Tarui
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

9.  Suppression of induced erythrocyte autoantibodies is dependent on Lyt 1 cells.

Authors:  P Hutchings; S Marshall-Clarke; A Cooke
Journal:  Immunology       Date:  1985-10       Impact factor: 7.397

10.  Breeding of a non-obese, diabetic strain of mice.

Authors:  S Makino; K Kunimoto; Y Muraoka; Y Mizushima; K Katagiri; Y Tochino
Journal:  Jikken Dobutsu       Date:  1980-01
View more
  72 in total

Review 1.  Immunotherapy of immune-mediated diabetes. Present and future.

Authors:  N Maclaren
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

2.  DNA vaccination encoding glutamic acid decarboxylase can enhance insulitis and diabetes in correlation with a specific Th2/3 CD4 T cell response in non-obese diabetic mice.

Authors:  A Gauvrit; M Debailleul; A-T Vu; P Sai; J-M Bach
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

Review 3.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

Review 4.  CD4+ Tregs and immune control.

Authors:  Zoltán Fehérvari; Shimon Sakaguchi
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

5.  Chromosomal localization, DNA polymorphism, and expression of Rt-6, the mouse homologue of rat T-lymphocyte differentiation marker RT6.

Authors:  M Prochazka; H R Gaskins; E H Leiter; F Koch-Nolte; F Haag; H G Thiele
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

Review 6.  Special regulatory T-cell review: Regulatory T cells and the intestinal tract--patrolling the frontier.

Authors:  Ana Izcue; Fiona Powrie
Journal:  Immunology       Date:  2008-01       Impact factor: 7.397

Review 7.  The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.

Authors:  S L Cardell
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

8.  Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.

Authors:  N Chosich; L C Harrison
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

9.  Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer.

Authors:  M J Clare-Salzler; J Brooks; A Chai; K Van Herle; C Anderson
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

10.  An anergic, islet-infiltrating T-cell clone that suppresses murine diabetes secretes a factor that blocks interleukin 2/interleukin 4-dependent proliferation.

Authors:  C Díaz-Gallo; M Moscovitch-Lopatin; T B Strom; V R Kelley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.